Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease
CA 2323063 A1 · Owner: University Of Dundee · Inventors: Watts, Colin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of modulating the immune response in a patient in need of such modulation, the method comprising administering to the patient an effective amount of an inhibitor of asparaginyl endopeptidase. A method of reducing the processing of a protein antigen by a MHC Class II molecule by a cell the , method comprising contacting the cell with an inhibitor of asparaginyl endopeptidase.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 26, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 26, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 26, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.